Patent directory · USPTO A61K / A61P
Patents matching “Theravance Biopharma R&D IP, LLC”
252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11254669
Fused imidazo-piperidine JAK inhibitors
granted -
US 11254655
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
granted -
US 11247969
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 11230536
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
granted -
US 11174219
Neprilysin inhibitors
granted -
US 11160800
Methods of treatment using a JAK inhibitor compound
granted -
US 11160810
Fused imidazo-piperidine JAK inhibitor compound
granted -
US 11155549
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
granted -
US 11124502
Neprilysin inhibitors
granted -
US 11110095
Pyrimidine compounds as JAK kinase inhibitors
granted -
US 11033533
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
granted -
US 11008289
Crystalline freebase forms of a biphenyl compound
granted -
US 10988470
Pyrimidine compound as JAK kinase inhibitor
granted -
US 10968205
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
granted -
US 10968222
2-azabicyclo hexane JAK inhibitor compound
granted -
US 10961267
Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
granted -
US 10952996
ALK5 inhibitors
granted -
US 10954237
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10946009
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
granted -
US 10947254
Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
granted -
US 10946007
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
granted -
US 10946006
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
granted -
US 10913740
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 10851102
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
granted